These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10680430)

  • 1. MMA reviews prescription drug plans.
    Minn Med; 2000 Jan; 83(1):35-6. PubMed ID: 10680430
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Medicare prescription drug plan: assisting our older patients.
    Klein MN
    ORL Head Neck Nurs; 2004; 22(4):34-5. PubMed ID: 15617318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Part I--Medicare prescription drug coverage (Part D): the promise.
    Witten B
    Nephrol News Issues; 2006 Jul; 20(8):14, 17-8. PubMed ID: 16859229
    [No Abstract]   [Full Text] [Related]  

  • 5. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
    Emmer S; Allendorf L
    J Am Geriatr Soc; 2004 Jun; 52(6):1013-5. PubMed ID: 15161471
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparing prescription drug plans. New choices made available by Medicare Part D deserve serious study.
    AVMA Group Health & Life Insurance Trust
    J Am Vet Med Assoc; 2005 Dec; 227(12):1884-5. PubMed ID: 16382541
    [No Abstract]   [Full Text] [Related]  

  • 7. What will the new medicare drug benefit mean for Minnesota physicians?
    Liebow M
    Minn Med; 2005 Mar; 88(3):38-41. PubMed ID: 15852596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A first look at the new Medicare prescription drug plans.
    Frakt AB; Pizer SD
    Health Aff (Millwood); 2006; 25(4):W252-61. PubMed ID: 16720588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affordable prescription drugs--state and federal action.
    Ohio Nurses Rev; 2003 Aug; 78(7):4. PubMed ID: 15134064
    [No Abstract]   [Full Text] [Related]  

  • 10. Medicare prescription drug/reform act: medicine chest or Pandora's box?
    Hager MH
    J Am Diet Assoc; 2004 Jun; 104(6):890-1. PubMed ID: 15175585
    [No Abstract]   [Full Text] [Related]  

  • 11. Access to Medicare Part D gap coverage more scarce in 2007.
    Consult Pharm; 2007 Jan; 22(1):60-1. PubMed ID: 17380599
    [No Abstract]   [Full Text] [Related]  

  • 12. The first months of the prescription-drug benefit--a CMS update.
    Bach PB; McClellan MB
    N Engl J Med; 2006 Jun; 354(22):2312-4. PubMed ID: 16738266
    [No Abstract]   [Full Text] [Related]  

  • 13. Medicare and the politics of prescription drug pricing.
    Oberlander J
    N C Med J; 2003; 64(6):303-4. PubMed ID: 14983626
    [No Abstract]   [Full Text] [Related]  

  • 14. Medicare program: Medicare Advantage and Prescription Drug Benefit programs: final marketing provisions. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Sep; 73(182):54207-23. PubMed ID: 18985950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinton proposal begins debate on Medicare prescription benefit.
    Weiss HP
    Balance; 1999; 3(5):6-7. PubMed ID: 10662381
    [No Abstract]   [Full Text] [Related]  

  • 16. Advocating for a Medicare prescription drug benefit.
    Rother J
    Yale J Health Policy Law Ethics; 2003; 3(2):279-90. PubMed ID: 14577144
    [No Abstract]   [Full Text] [Related]  

  • 17. Medicare prescription drug coverage (part D): challenges and opportunities.
    Witten B
    Nephrol News Issues; 2006 Aug; 20(9):14-6, 18. PubMed ID: 16916055
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceuticals: Medicare Modernization Act--2005. End of Year Issue Brief.
    Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-21. PubMed ID: 16710928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare Program; revisions to the Medicare Advantage and Prescription Drug Benefit programs. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Sep; 73(182):54225-54. PubMed ID: 18985953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicare prescription drug plans: the impact on physician practice.
    Marable S
    Med Health R I; 2006 Jan; 89(1):39-40. PubMed ID: 16519205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.